Gilead Sciences (GILD)
$65.27
1.81 (2.70%)
GILD Stock Quote Delayed 30 Minutes
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024
GILD stock results show that Gilead Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
81.84B
PE Ratio
14.54
EPS
4.49
Volume (Avg. Vol.)
15.17M
Day's Range
$65.09 - $67.90
52-Week Range
$65.09 - $87.86
Dividend & Yield
$3.00 (4.60%)
GILD Stock Predictions, Articles, and Gilead Sciences News
7 Value Stocks to Buy at a 52-Week Low in March
These seven value stocks to buy all trade at low valuations, and have the potential to make big recoveries.
Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?
While Wall Street obsesses over weight-loss drugs, Gilead Sciences is working on life-saving treatments and GILD stock looks ready to rally.
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK.
Why Is Compugen (CGEN) Stock Up 189% Today?
Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.
Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?
Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!
GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment
Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.
